Jamie Freedman, Md, Phd Email & Phone Number

>20 years at 4 of the top 10 large Pharma companies in R&D/Commercial/Medical leadership roles resulting in 15 drug approvals/launches across therapeutic areas, including a blockbuster cancer immunotherapy drug taken from discovery through launch. CEO of a drug discovery biotech completing multiple Pharma partnership deals. Practicing Hematologist-Oncologist and early career as a Biochemist/Structural Biologist with multiple peer-reviewed publications. Mentored numerous physician-scientists to become healthcare leaders. Led some of the first clinical trials enriched in underrepresented patients in the US and Africa, one of which was used to gain FDA approval of a COVID-19 pneumonia therapy for access, especially in underserved communities. Currently focused on health equity research and reimbursable drug access of innovative medicines in Sub-Sahahran Africa and clinical consultant for multiple biotech companies.